Watch CAH. Know when insiders buy.
One email the day a filing lands. Free.
Work order
42
WATCH · insiders 25, shorts 58
Insiders, 90 days
−$59.6M
net selling · 0 buys, 31 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
3 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $57.5BP/E —DIV YIELD 0.83%FCF YIELD 7.87%REV TTM $254.2B +14.2%NET INCOME $1.7B +9.8%NET CASH $2.4B52W 147.47 – 248.61SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Dec 31 | $65.6B | +18.8% | 3.7% | $707M | $467M | +16.8% | — | $686M | $131M | $555M | Feb 5 |
| Q1 2026 · Sep 30 | $64B | +22.4% | 3.6% | $668M | $450M | +8.2% | — | $973M | $108M | $865M | Oct 30 |
| Q4 2025 · Jun 30derived | $60.2B | +0.5% | 3.7% | $428M | $239M | +1.7% | — | $1.5B | $232M | $1.3B | Aug 11 |
| Q3 2025 · Mar 31 | $54.9B | +0.0% | 3.9% | $730M | $506M | +93.9% | — | $2.9B | $126M | $2.8B | May 1 |
| Q2 2025 · Dec 31 | $55.3B | −3.8% | 3.5% | $549M | $400M | +8.7% | — | −$396M | $99M | −$495M | Feb 5 |
| Q1 2025 · Sep 30 | $52.3B | −4.3% | 3.6% | $568M | $416M | — | — | −$1.6B | $90M | −$1.7B | Oct 30 |
| Q4 2024 · Jun 30derived | $59.9B | +12.1% | 3.1% | $401M | $235M | +4600.0% | — | $2.1B | $193M | $1.9B | Aug 11 |
| Q3 2024 · Mar 31 | $54.9B | +8.7% | 3.5% | $369M | $261M | −28.5% | — | −$27M | $112M | −$139M | May 1 |
| Q2 2024 · Dec 31 | $57.4B | — | 3.2% | $505M | $368M | — | — | $1.2B | $114M | $1.1B | Jan 30 |
| Q1 2024 · Sep 30 | $54.6B | — | 3.2% | −$32M | −$12M | — | — | $528M | $92M | $436M | Nov 1 |
| Q4 2023 · Jun 30derived | $53.4B | — | 3.4% | $162M | $5M | — | — | $863M | $217M | $646M | Aug 12 |
| Q3 2023 · Mar 31 | $50.5B | — | 3.6% | $604M | $365M | — | — | $1.4B | $109M | $1.3B | Aug 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Jun 30 | $254.2B | 3.8% | $2.6B | $1.7B | 0.7% | — | $5.2B | $649M | $4.5B | $1.4B | $491M |
| FY2025 · to Jun 30 | $222.6B | 3.7% | $2.3B | $1.6B | 0.7% | — | $2.4B | $547M | $1.9B | $765M | $494M |
| FY2024 · to Jun 30 | $226.8B | 3.3% | $1.2B | $852M | 0.4% | — | $3.8B | $511M | $3.3B | $750M | $499M |
| FY2023 · to Jun 30 | $205B | 3.4% | $752M | $330M | 0.2% | — | $2.8B | $481M | $2.4B | $2B | $525M |
| FY2022 · to Jun 30 | $181.3B | 3.6% | −$607M | −$938M | -0.5% | — | $3.2B | $387M | $2.8B | $1B | $559M |
| FY2021 · to Jun 30 | $162.5B | 4.2% | $472M | $611M | 0.4% | — | $2.4B | $400M | $2B | $200M | $573M |
Every number comes from CARDINAL HEALTH INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.